Sunday, October 26, 2025

Cognetivity Looks To Raise $3.0 Million To Fund US Expansion

Cognetivity Neurosciences (CSE: CGN) is looking to close out the year with a capital raise. The firm last night indicated it intends to conduct a non-brokered private placement for gross proceeds of $3.0 million.

The financing will see the company sell roughly 5.5 million units, with each unit being priced at $0.55 per each. Each unit is set to contain one common share and one half of a purchase warrant, with each warrant valid for a period of three years and containing an exercise price of $0.85 per share.

Proceeds from the offering are to be used to expand the firms operations in the US, customer and technical support, marketing, and general operations.

The financing is currently slated to close by January 31, 2022.

Cognetivity Neuroscience last traded at $0.56 on the CSE.


FULL DISCLOSURE: Cognetivity Neurosciences Ltd is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Cognetivity Neurosciences Ltd on The Deep Dive, with The Deep Dive having full editorial control. We may buy or sell securities in the company at any time. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.

Video Articles

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

This Is Why the Gold Run Is Not Done! | Peter Marrone – Allied Gold

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

Cognetivity Sees Pilot Program Transition Into Commercial Agreement In UAE

A successful pilot program has lead to a commercial arrangement for Cognetivity Neurosciences (CSE: CGN)....

Wednesday, June 15, 2022, 07:23:20 AM

Cognetivity Expands To Asian Market Via Pilot Program In Singapore

Cognetivity Neurosciences (CSE: CGN) continues to expand upon its global reach, this morning announcing its...

Tuesday, July 5, 2022, 08:01:43 AM

Cognetivity Neurosciences Files Patent For System Capable Of Early Detection Of Alzheimer’s Disease

Cognetivity Neurosciences (CSE: CGN) this morning announced that it has filed for a key new...

Tuesday, June 8, 2021, 10:08:19 AM

Cognetivity Neurosciences Sees Former UK Health Minister Appointed To Advisory Board

Cognetivity Neurosciences (CSE: CGN) this morning announced that it has added a former UK Health...

Monday, April 12, 2021, 09:09:04 AM

Cognetivity’s Assessment Tool To Be Deployed At KetamineOne Clinics Across North America

Cognetivity Neurosciences (CSE: CGN) will soon see its cognitive assessment tool for the early detection...

Wednesday, September 1, 2021, 08:22:59 AM